- Home
- ABLV vs CCEL Comparison
ABLV vs CCEL Comparison
Compare ABLV & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLV
- CCEL
- Stock Information
- Founded
- ABLV 2015
- CCEL 1989
- Country
- ABLV China
- CCEL United States
- Employees
- ABLV N/A
- CCEL N/A
- Industry
- ABLV
- CCEL Managed Health Care
- Sector
- ABLV
- CCEL Health Care
- Exchange
- ABLV Nasdaq
- CCEL Nasdaq
- Market Cap
- ABLV 32.9M
- CCEL 35.8M
- IPO Year
- ABLV N/A
- CCEL 1997
- Fundamental
- Price
- ABLV $0.65
- CCEL $4.30
- Analyst Decision
- ABLV
- CCEL Hold
- Analyst Count
- ABLV 0
- CCEL 1
- Target Price
- ABLV N/A
- CCEL N/A
- AVG Volume (30 Days)
- ABLV 9.4K
- CCEL 4.3K
- Earning Date
- ABLV 12-19-2025
- CCEL 10-15-2025
- Dividend Yield
- ABLV N/A
- CCEL 9.30%
- EPS Growth
- ABLV N/A
- CCEL N/A
- EPS
- ABLV 0.05
- CCEL N/A
- Revenue
- ABLV $114,319,869.00
- CCEL $31,747,500.00
- Revenue This Year
- ABLV N/A
- CCEL $0.30
- Revenue Next Year
- ABLV N/A
- CCEL N/A
- P/E Ratio
- ABLV $14.37
- CCEL N/A
- Revenue Growth
- ABLV N/A
- CCEL N/A
- 52 Week Low
- ABLV $0.55
- CCEL $4.00
- 52 Week High
- ABLV $1.77
- CCEL $9.10
- Technical
- Relative Strength Index (RSI)
- ABLV 39.23
- CCEL 51.29
- Support Level
- ABLV $0.61
- CCEL $4.04
- Resistance Level
- ABLV $0.70
- CCEL $4.45
- Average True Range (ATR)
- ABLV 0.06
- CCEL 0.13
- MACD
- ABLV -0.00
- CCEL 0.03
- Stochastic Oscillator
- ABLV 33.16
- CCEL 67.26
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.